Skip to main content
Top
Published in: Head & Neck Oncology 1/2010

Open Access 01-12-2010 | Research

Sentinel lymph node mapping by indocyanin green fluorescence imaging in oropharyngeal cancer - preliminary experience

Author: Marius G Bredell

Published in: Head & Neck Oncology | Issue 1/2010

Login to get access

Abstract

Background

Sentinel lymph node (SLN) detection and biopsy is gaining popularity in the treatment of Head and Neck cancer. Various methods in this regard have been described, each with their respective advantages and disadvantages. The aim of this paper was to evaluate the potential application of Indocyanin Green (ICG) in the mapping and detection of sentinel lymph nodes (SLN) in cancers of the head and neck.

Methods

Patients with oropharyngeal cancer and N0 neck who were scheduled for primary tumor ablation as well as a neck dissection were selected. One milliliter of Indocyanin green was injected around the tumor and the sentinel node detection was performed by aiming the infra red video camera on the cervical area. When no detection was possible transcutaneously, a cervical incision was made, a sub-platysmal flap raised and further detection was done to visualize the fluorescing lymph nodes.

Results

Detection of cervical SLN was only possible when 5 mm or less tissue covered the sentinel lymph node. Accurate and clear detection of the lymph drainage pattern and SLN was possible. There is some uptake in other tissues such as the submandibular gland which is easily distinguishable from lymphatic tissue.

Conclusion

Indocyanin green fluorescence is a potential valuable potential tool in the detection of SLN in patients with oropharyngeal cancer which warrants further investigation.
Appendix
Available only for authorised users
Literature
1.
go back to reference Capote A, Escorial V, Muñoz-Guerra MF, et al: Elective neck dissection in early-stage oral squamous cell carcinoma--does it influence recurrence and survival?. Head and Neck. 2007, 29: 3-11. 10.1002/hed.20482.CrossRefPubMed Capote A, Escorial V, Muñoz-Guerra MF, et al: Elective neck dissection in early-stage oral squamous cell carcinoma--does it influence recurrence and survival?. Head and Neck. 2007, 29: 3-11. 10.1002/hed.20482.CrossRefPubMed
2.
go back to reference Alkureishi LWT, Ross GL, MacDonald G, et al: Sentinel nodes in head and neck cancer: use of size criterion to upstage the N0 neck in head and neck squamous cell carcinoma. Head Neck. 2007, 29: 95-103. 10.1002/hed.20486.CrossRefPubMed Alkureishi LWT, Ross GL, MacDonald G, et al: Sentinel nodes in head and neck cancer: use of size criterion to upstage the N0 neck in head and neck squamous cell carcinoma. Head Neck. 2007, 29: 95-103. 10.1002/hed.20486.CrossRefPubMed
3.
go back to reference Ross GL, Soutar S, Shoaib T, et al: The ability of lymphoscintigraphy to direct sentinel node biopsy in the clinically N0 neck for patients with head and neck squamous cell carcinoma. The British Journal of Radiology. 2002, 75: 950-958.CrossRefPubMed Ross GL, Soutar S, Shoaib T, et al: The ability of lymphoscintigraphy to direct sentinel node biopsy in the clinically N0 neck for patients with head and neck squamous cell carcinoma. The British Journal of Radiology. 2002, 75: 950-958.CrossRefPubMed
4.
go back to reference Stokkel MP, ten Broek FW, Hordijk GJ, et al: Preoperative evaluation of patients with primary head and neckcancer using dual-head 18 fluorodeoxyglucose positron emission tomography. Ann Surg. 2000, 231: 229-34. 10.1097/00000658-200002000-00012.PubMedCentralCrossRefPubMed Stokkel MP, ten Broek FW, Hordijk GJ, et al: Preoperative evaluation of patients with primary head and neckcancer using dual-head 18 fluorodeoxyglucose positron emission tomography. Ann Surg. 2000, 231: 229-34. 10.1097/00000658-200002000-00012.PubMedCentralCrossRefPubMed
5.
go back to reference Muylle K, Castaigne C, Flamen P: 18F-fluoro-2-deoxy-D-glucose positron emission tomographic imaging: recent developments in head and neck cancer. Current Opinion in Oncology. 2005, 17: 249-253. 10.1097/01.cco.0000160276.78762.17.CrossRefPubMed Muylle K, Castaigne C, Flamen P: 18F-fluoro-2-deoxy-D-glucose positron emission tomographic imaging: recent developments in head and neck cancer. Current Opinion in Oncology. 2005, 17: 249-253. 10.1097/01.cco.0000160276.78762.17.CrossRefPubMed
6.
go back to reference Righi PD, Kopecky KK, Caldemeyer KS, et al: Comparison of ultrasound-fine needle aspiration and computed tomography in patients undergoing elective neck dissection. Head Neck. 1997, 19: 604-610. 10.1002/(SICI)1097-0347(199710)19:7<604::AID-HED7>3.0.CO;2-B.CrossRefPubMed Righi PD, Kopecky KK, Caldemeyer KS, et al: Comparison of ultrasound-fine needle aspiration and computed tomography in patients undergoing elective neck dissection. Head Neck. 1997, 19: 604-610. 10.1002/(SICI)1097-0347(199710)19:7<604::AID-HED7>3.0.CO;2-B.CrossRefPubMed
7.
go back to reference Ambrosch P, Brinck U: Detection of nodal micrometastasis in head and neck cancer by serial sectioning and immunostaining. Oncology (Huntingt). 1996, 10: 1221-1226. Ambrosch P, Brinck U: Detection of nodal micrometastasis in head and neck cancer by serial sectioning and immunostaining. Oncology (Huntingt). 1996, 10: 1221-1226.
8.
go back to reference Stacker SA, Achen MG, Jussila L, et al: Lymphangiogenesis and cancer metastasis. Nat Rev Cancer. 2002, 2: 573-583. 10.1038/nrc863.CrossRefPubMed Stacker SA, Achen MG, Jussila L, et al: Lymphangiogenesis and cancer metastasis. Nat Rev Cancer. 2002, 2: 573-583. 10.1038/nrc863.CrossRefPubMed
9.
go back to reference Seaman WB, Powers WE: Studies on the distribution of radioactive colloidal gold in regional lymph nodes containing cancer. Cancer. 1955, 8: 1044-1046. 10.1002/1097-0142(1955)8:5<1044::AID-CNCR2820080530>3.0.CO;2-6.CrossRefPubMed Seaman WB, Powers WE: Studies on the distribution of radioactive colloidal gold in regional lymph nodes containing cancer. Cancer. 1955, 8: 1044-1046. 10.1002/1097-0142(1955)8:5<1044::AID-CNCR2820080530>3.0.CO;2-6.CrossRefPubMed
10.
go back to reference Gould EA, Winship T, Philbin PH, et al: Observations on a 'sentinel node' in cancer of the parotid. Cancer. 1960, 13: 77-78. 10.1002/1097-0142(196001/02)13:1<77::AID-CNCR2820130114>3.0.CO;2-D.CrossRefPubMed Gould EA, Winship T, Philbin PH, et al: Observations on a 'sentinel node' in cancer of the parotid. Cancer. 1960, 13: 77-78. 10.1002/1097-0142(196001/02)13:1<77::AID-CNCR2820130114>3.0.CO;2-D.CrossRefPubMed
11.
go back to reference Shah JP, Candela FC, Poddar AK: The patterns of cervical lymph node metastases from squamous carcinoma of the oral cavity. Cancer. 1990, 66: 109-113. 10.1002/1097-0142(19900701)66:1<109::AID-CNCR2820660120>3.0.CO;2-A.CrossRefPubMed Shah JP, Candela FC, Poddar AK: The patterns of cervical lymph node metastases from squamous carcinoma of the oral cavity. Cancer. 1990, 66: 109-113. 10.1002/1097-0142(19900701)66:1<109::AID-CNCR2820660120>3.0.CO;2-A.CrossRefPubMed
12.
go back to reference Byers RB, Clayman GL, McGill D, et al: Selective neck dissections for squamous carcinoma of the upper aerodigestive tract: Patterns of regional failure. Head and Neck. 1999, 21 (6): 499-505. 10.1002/(SICI)1097-0347(199909)21:6<499::AID-HED1>3.0.CO;2-A.CrossRefPubMed Byers RB, Clayman GL, McGill D, et al: Selective neck dissections for squamous carcinoma of the upper aerodigestive tract: Patterns of regional failure. Head and Neck. 1999, 21 (6): 499-505. 10.1002/(SICI)1097-0347(199909)21:6<499::AID-HED1>3.0.CO;2-A.CrossRefPubMed
13.
go back to reference Koch WM, Choti MA, Civelek AC, et al: Gamma probe-directed biopsy of the sentinel node in oral squamous cell carcinoma. Arch Otolaryngol Head and Neck Surg. 1998, 124: 455-459.CrossRef Koch WM, Choti MA, Civelek AC, et al: Gamma probe-directed biopsy of the sentinel node in oral squamous cell carcinoma. Arch Otolaryngol Head and Neck Surg. 1998, 124: 455-459.CrossRef
14.
go back to reference Ross GL, Shoaib T, Soutar DS, et al: The First International Conference on Sentinel node biopsy in mucosal head and neck cancer and adoption of a multicenter trial protocol. Ann Surg Oncol. 2002, 9: 406-410. 10.1007/BF02573877.CrossRefPubMed Ross GL, Shoaib T, Soutar DS, et al: The First International Conference on Sentinel node biopsy in mucosal head and neck cancer and adoption of a multicenter trial protocol. Ann Surg Oncol. 2002, 9: 406-410. 10.1007/BF02573877.CrossRefPubMed
15.
go back to reference Fox IJ, Brooker LG, Heseltine DW, Essex HE, Wood EH: A Tricarbocyanine dye for continuous recording of dilution curves in whole blood independent of variations in blood oxygen saturation. Proc Staff Meet Myo Clin. 1957, 32 (18): 478-484. Fox IJ, Brooker LG, Heseltine DW, Essex HE, Wood EH: A Tricarbocyanine dye for continuous recording of dilution curves in whole blood independent of variations in blood oxygen saturation. Proc Staff Meet Myo Clin. 1957, 32 (18): 478-484.
16.
go back to reference Cherrick GR, Stein SW, Leevy CM, Davidson CS: Indocyanine green: observations of its physical properties, plasma decay, and hepatic extraction. J Clin Invest. 1960, 39: 592-600. 10.1172/JCI104072.PubMedCentralCrossRefPubMed Cherrick GR, Stein SW, Leevy CM, Davidson CS: Indocyanine green: observations of its physical properties, plasma decay, and hepatic extraction. J Clin Invest. 1960, 39: 592-600. 10.1172/JCI104072.PubMedCentralCrossRefPubMed
17.
go back to reference Norimasa Ito, Mikihisa Fukuta, Takeshi Tokushima, Kaoru Nakai, Shigetsugu Ohgi: Sentinel Node Navigation Surgery Using Indocyanine Green in Patients with Lung Cancer. Surg Today. 2004, 34: 581-585. Norimasa Ito, Mikihisa Fukuta, Takeshi Tokushima, Kaoru Nakai, Shigetsugu Ohgi: Sentinel Node Navigation Surgery Using Indocyanine Green in Patients with Lung Cancer. Surg Today. 2004, 34: 581-585.
18.
go back to reference Murawa D, Hirche C, Dresel S, Hünerbein M: Sentinel lymph node biopsy in breast cancer guided by indocyanine green fluorescence. British Journal of Surgery. 2009, 96: 1289-1294. 10.1002/bjs.6721.CrossRefPubMed Murawa D, Hirche C, Dresel S, Hünerbein M: Sentinel lymph node biopsy in breast cancer guided by indocyanine green fluorescence. British Journal of Surgery. 2009, 96: 1289-1294. 10.1002/bjs.6721.CrossRefPubMed
19.
go back to reference Tajima Y, Yamazaki K, Masuda Y, et al: Sentinel Node Mapping Guided by Indocyanine Green Fluorescence Imaging in Gastric Cancer. Annals of Surgery. 2009, 249 (1): 58-62. 10.1097/SLA.0b013e3181927267.CrossRefPubMed Tajima Y, Yamazaki K, Masuda Y, et al: Sentinel Node Mapping Guided by Indocyanine Green Fluorescence Imaging in Gastric Cancer. Annals of Surgery. 2009, 249 (1): 58-62. 10.1097/SLA.0b013e3181927267.CrossRefPubMed
20.
go back to reference Miyashiro I, Miyoshi N, Hiratsuka M, et al: Detection of Sentinel Node in Gastric Cancer Surgery by Indocyanine Green Fluorescence Imaging: Comparison with Infrared. Ann Surg Oncol. 2008, 15 (6): 1640-3. 10.1245/s10434-008-9872-7.CrossRefPubMed Miyashiro I, Miyoshi N, Hiratsuka M, et al: Detection of Sentinel Node in Gastric Cancer Surgery by Indocyanine Green Fluorescence Imaging: Comparison with Infrared. Ann Surg Oncol. 2008, 15 (6): 1640-3. 10.1245/s10434-008-9872-7.CrossRefPubMed
21.
go back to reference Ishikawa K, Yasuda K, Shiromizu A, et al: Laparoscopic sentinel node navigation achieved by infrared ray electronic endoscopy system in patients with gastric cancer. Surg Endosc. 2007, 21: 1131-1134. 10.1007/s00464-006-9062-2.CrossRefPubMed Ishikawa K, Yasuda K, Shiromizu A, et al: Laparoscopic sentinel node navigation achieved by infrared ray electronic endoscopy system in patients with gastric cancer. Surg Endosc. 2007, 21: 1131-1134. 10.1007/s00464-006-9062-2.CrossRefPubMed
22.
go back to reference Fujiwara M, Mizukami T, Suzuki A, Fukamizu H: Sentinel lymph node detection in skin cancer patients using real-time fluorescence navigation with indocyanine green: preliminary experience. Journal of Plastic, Reconstructive & Aesthetic Surgery. 2009, 373-378. 62 Fujiwara M, Mizukami T, Suzuki A, Fukamizu H: Sentinel lymph node detection in skin cancer patients using real-time fluorescence navigation with indocyanine green: preliminary experience. Journal of Plastic, Reconstructive & Aesthetic Surgery. 2009, 373-378. 62
23.
go back to reference Stoeckeli SJ: Sentinel node biopsy for oral and oropharyngeal squamous cell carcinoma of the head and neck. Laryngoscope. 2007, 117: 1539-1551. 10.1097/MLG.0b013e318093ee67.CrossRef Stoeckeli SJ: Sentinel node biopsy for oral and oropharyngeal squamous cell carcinoma of the head and neck. Laryngoscope. 2007, 117: 1539-1551. 10.1097/MLG.0b013e318093ee67.CrossRef
24.
go back to reference Bilde A, von Buchwald C, Therkildsen MH, et al: Need for intensive histopathologic analysis to determine lymph node metastases when using sentinel node biopsy in oral cancer. Laryngoscope. 2008, 118: 408-414. 10.1097/MLG.0b013e31815d8e15.CrossRefPubMed Bilde A, von Buchwald C, Therkildsen MH, et al: Need for intensive histopathologic analysis to determine lymph node metastases when using sentinel node biopsy in oral cancer. Laryngoscope. 2008, 118: 408-414. 10.1097/MLG.0b013e31815d8e15.CrossRefPubMed
25.
go back to reference Cundiff JD, Wang Y Z, Espenan G, et al: A phase I/II trial of 125I methylene blue for one-stage sentinel lymph node biopsy. Annals of Surgery. 2007, 245 (2): 290-296. 10.1097/01.sla.0000242712.74502.72.PubMedCentralCrossRefPubMed Cundiff JD, Wang Y Z, Espenan G, et al: A phase I/II trial of 125I methylene blue for one-stage sentinel lymph node biopsy. Annals of Surgery. 2007, 245 (2): 290-296. 10.1097/01.sla.0000242712.74502.72.PubMedCentralCrossRefPubMed
Metadata
Title
Sentinel lymph node mapping by indocyanin green fluorescence imaging in oropharyngeal cancer - preliminary experience
Author
Marius G Bredell
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Head & Neck Oncology / Issue 1/2010
Electronic ISSN: 1758-3284
DOI
https://doi.org/10.1186/1758-3284-2-31

Other articles of this Issue 1/2010

Head & Neck Oncology 1/2010 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine